INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
1. Pomerantz LLP is investigating Fulgent Genetics for potential securities fraud. 2. Fulgent received a civil investigative demand from the DOJ concerning false claims. 3. Stock price fell 2.61% following news, closing at $15.28 as of March 3, 2025. 4. Investors are encouraged to join the class action regarding these claims. 5. The firm's history includes numerous successful recoveries for class members.